510(k) Report

FDA applicant

Nxstage Medical, Inc.

Lawrence, MA51 decisions2001–202451 recalls

FDA records 51 decisions for Nxstage Medical, Inc. (Lawrence, MA) from 2001 to 2024: 51 510(k) clearances. Most are in product codes KDI (Dialyzer, High Permeability With Or Without…) and KPO (Dialysate Concentrate For Hemodialysis (Liquid…). Since 2016 its 510(k)s took a median of 135 days from receipt to decision, against 188 for FDA’s reviews in the same codes and years. Its devices cite 75 predicates, 40 of them its own earlier devices. 51 recalls are linked to its devices, 7 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, gastroenterology and urology panel, where it files most

How often FDA has decided Nxstage Medical, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2024

2007: 12008: 32009: 12010: 12011: 12012: 12013: 52014: 72015: 22017: 22018: 12019: 12023: 12024: 2
2007high 7 (2014) · low 0 (2016)2026

2026 so far, outlined.

Recalls per year

6in 2026

2007: 12011: 12013: 12014: 92015: 52017: 12018: 102019: 32024: 92025: 2, 1 Class I2026 (partial year): 6, 6 Class I
2007high 10 (2018) · low 0 (2008)2026

Class I Class II/III not classified

FIG. 1 — Nxstage Medical, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Nxstage Medical, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report